172 related articles for article (PubMed ID: 1672340)
1. Phenotypic characterization of murine tumor-infiltrating T lymphocytes.
Karpati RM; Banks SM; Malissen B; Rosenberg SA; Sheard MA; Weber JS; Hodes RJ
J Immunol; 1991 Mar; 146(6):2043-51. PubMed ID: 1672340
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and functional analysis of murine CD3+,CD4-,CD8- TCR-gamma delta-expressing peripheral T cells.
Cron RQ; Gajewski TF; Sharrow SO; Fitch FW; Matis LA; Bluestone JA
J Immunol; 1989 Jun; 142(11):3754-62. PubMed ID: 2523934
[TBL] [Abstract][Full Text] [Related]
3. T lymphocytes that express CD4 and the alpha beta-T cell receptor but lack Thy-1. Preferential localization in Peyer's patches.
Harriman GR; Lycke NY; Elwood LJ; Strober W
J Immunol; 1990 Oct; 145(8):2406-14. PubMed ID: 1976693
[TBL] [Abstract][Full Text] [Related]
4. Differential in situ expansion and gene expression of CD4+ and CD8+ tumor-infiltrating lymphocytes following adoptive immunotherapy in a murine tumor model system.
Evans R; Duffy TM; Kamdar SJ
Eur J Immunol; 1991 Aug; 21(8):1815-9. PubMed ID: 1907916
[TBL] [Abstract][Full Text] [Related]
5. Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma.
Choudhary A; Davodeau F; Moreau A; Peyrat MA; Bonneville M; Jotereau F
J Immunol; 1995 Apr; 154(8):3932-40. PubMed ID: 7706731
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic efficacy of murine anti-tumor T cells: freshly isolated T cells are more therapeutic than T cells expanded in vitro.
Evans R; Kamdar SJ; Duffy TM; Krupke DM; Fuller JA; Dudley ME
Anticancer Res; 1995; 15(2):441-7. PubMed ID: 7763019
[TBL] [Abstract][Full Text] [Related]
7. Characterization of V beta-bearing cells in athymic (nu/nu) mice suggests an extrathymic pathway for T cell differentiation.
Rocha B
Eur J Immunol; 1990 Apr; 20(4):919-25. PubMed ID: 1971795
[TBL] [Abstract][Full Text] [Related]
8. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.
Peoples GE; Davey MP; Goedegebuure PS; Schoof DD; Eberlein TJ
J Immunol; 1993 Nov; 151(10):5472-80. PubMed ID: 8228239
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and in vivo homing of long-term T-cell lines and clones derived from tumor-draining lymph nodes.
Matsumura T; Sussman JJ; Krinock RA; Chang AE; Shu S
Cancer Res; 1994 May; 54(10):2744-50. PubMed ID: 8168105
[TBL] [Abstract][Full Text] [Related]
10. Novel function for intestinal intraepithelial lymphocytes. Murine CD3+, gamma/delta TCR+ T cells produce IFN-gamma and IL-5.
Taguchi T; Aicher WK; Fujihashi K; Yamamoto M; McGhee JR; Bluestone JA; Kiyono H
J Immunol; 1991 Dec; 147(11):3736-44. PubMed ID: 1682383
[TBL] [Abstract][Full Text] [Related]
11. Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma-infiltrating lymphocytes.
Pandolfino MC; Viret C; Gervois N; Guilloux Y; Davodeau F; Diez E; Jotereau F
Eur J Immunol; 1992 Jul; 22(7):1795-802. PubMed ID: 1623924
[TBL] [Abstract][Full Text] [Related]
12. Characterization of T cell receptors on resident murine dendritic epidermal T cells.
Steiner G; Koning F; Elbe A; Tschachler E; Yokoyama WM; Shevach EM; Stingl G; Coligan JE
Eur J Immunol; 1988 Sep; 18(9):1323-8. PubMed ID: 2901962
[TBL] [Abstract][Full Text] [Related]
13. Regulatory function for murine intraepithelial lymphocytes. Two subsets of CD3+, T cell receptor-1+ intraepithelial lymphocyte T cells abrogate oral tolerance.
Fujihashi K; Taguchi T; McGhee JR; Eldridge JH; Bruce MG; Green DR; Singh B; Kiyono H
J Immunol; 1990 Oct; 145(7):2010-9. PubMed ID: 1975820
[TBL] [Abstract][Full Text] [Related]
14. Functional and phenotypic differences between CD4+ and CD4- T cell receptor-gamma delta clones from peripheral blood.
Spits H; Paliard X; Vandekerckhove Y; van Vlasselaer P; de Vries JE
J Immunol; 1991 Aug; 147(4):1180-8. PubMed ID: 1831219
[TBL] [Abstract][Full Text] [Related]
15. Unusual T cell populations in adult murine bone marrow. Prevalence of CD3+CD4-CD8- and alpha beta TCR+NK1.1+ cells.
Sykes M
J Immunol; 1990 Nov; 145(10):3209-15. PubMed ID: 1977798
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of rat T cell subpopulations expressing T cell receptors alpha/beta and gamma/delta.
Lawetzky A; Tiefenthaler G; Kubo R; Hünig T
Eur J Immunol; 1990 Feb; 20(2):343-9. PubMed ID: 2138084
[TBL] [Abstract][Full Text] [Related]
17. Gamma/delta T cell antigen receptors expressed on tumor-infiltrating lymphocytes from patients with solid tumors.
Nanno M; Seki H; Mathioudakis G; Suzuki R; Itoh K; Ioannides CG; Suzuki S; Chen PF; Platsoucas CD
Eur J Immunol; 1992 Mar; 22(3):679-87. PubMed ID: 1312472
[TBL] [Abstract][Full Text] [Related]
18. The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.
Weidmann E; Whiteside TL; Giorda R; Herberman RB; Trucco M
Cancer Res; 1992 Nov; 52(21):5913-20. PubMed ID: 1382847
[TBL] [Abstract][Full Text] [Related]
19. Fetal skin: a site of dendritic epidermal T cell development.
Elbe A; Kilgus O; Strohal R; Payer E; Schreiber S; Stingl G
J Immunol; 1992 Sep; 149(5):1694-701. PubMed ID: 1354679
[TBL] [Abstract][Full Text] [Related]
20. Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas.
Ikeda H; Sato N; Matsuura A; Kikuchi K
Cancer Res; 1993 Jul; 53(13):3078-84. PubMed ID: 8391386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
